Skip to content
Home » The Evolution of CAR T-Cell Therapy: From Blood Cancers to Solid Tumors

The Evolution of CAR T-Cell Therapy: From Blood Cancers to Solid Tumors

CAR T-cell therapy has transformed the treatment of blood cancers—but can it do the same for solid tumors?

This concise presentation explores the evolution of CAR T-cell therapy, tracing its breakthrough successes in hematologic malignancies and the complex scientific barriers limiting its effectiveness in solid tumors. It highlights key clinical milestones, explains the biological challenges researchers face today, and examines next-generation innovations shaping the future of cancer immunotherapy. A clear, forward-looking resource for anyone interested in where cellular cancer treatments are headed next.